Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification

Dysregulation of tyrosine kinase receptor (RTK) signaling pathways play important roles in glioblastoma (GBM). However, therapies targeting these signaling pathways have not been successful, partially because of drug resistance. Increasing evidence suggests that tumor heterogeneity, more specificall...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Bioeng Biotechnol
Main Authors: Chen, Si, Le, Thien, Harley, Brendan A. C., Imoukhuede, P. I.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Bioengineering and Biotechnology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6050407/
https://ncbi.nlm.nih.gov/pubmed/30050899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2018.00092
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados